Literature DB >> 25690981

Central serous chorioretinopathy fundus autofluorescence comparison with two different confocal scanning laser ophthalmoscopes.

Ki Tae Nam1, Cheol Min Yun1, Jee Taek Kim2, Kyung-Sook Yang3, Hyun Joo Kim4, Seong-Woo Kim5, Jaeryung Oh1, Kuhl Huh1.   

Abstract

PURPOSE: To compare the lesion characteristics of two different types of confocal scanning laser ophthalmoscopy (cSLO) autofluorescence (AF) images in central serous chorioretinopathy (CSC).
METHODS: The study included 63 eyes of 61 patients; 63 pairs of fundus autofluorescence (FAF) images were compared before CSC resolution in 63 eyes, FAF images of 31 eyes were also compared after CSC resolution. The lesion characteristics (brightness and composite pattern) were compared between Heidelberg Retina Angiograph 2 (HRA2; Heidelberg Engineering, Germany) and Optomap Tx (Optomap; Optos, Scotland) FAF images. The lesion composite pattern was categorized as diffuse or granular. Diffuse AF was defined as homogenously increased or decreased AF, and granular AF was defined as dot-like, coarse changes in AF. The mean disease duration and subretinal fluid (SRF) height in the spectral domain optical coherence tomography were compared according to the FAF image characteristics.
RESULTS: Lesion brightness before CSC resolution was hypo-AF in 48 eyes (76.2 %), hyper-AF in three (4.8 %), and mixed-AF in 12 (19.0 %) in HRA2 FAF images. In comparison, nine (14.3 %) images were hypo-AF, 44 (69.8 %) were hyper-AF, and 10 (15.9 %) were mixed-AF in Optomap FAF images (P < 0.0001). There was no significant difference in lesion composite pattern between the two FAF image wavelengths. Patients with lesions that were hyper-AF in Optomap FAF and hypo-AF in HRA2 FAF had a shorter disease duration and greater SRF height (1 month, 281 um) than those who were hyper-AF in both Optomap and HRA2 images (26 months, 153 um; P = 0.004, 0.001).
CONCLUSIONS: The two types of FAF images of CSC showed different lesion brightness before and after CSC resolution but demonstrated similar lesion composite patterns.

Entities:  

Keywords:  Central serous chorioretinopathy; Confocal scanning laser ophthalmoscopy; Fundus autofluorescence; Heidelberg Retina Angiograph; Optomap

Mesh:

Substances:

Year:  2015        PMID: 25690981     DOI: 10.1007/s00417-015-2958-6

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  20 in total

1.  Characterization of native retinal fluorophores involved in biosynthesis of A2E and lipofuscin-associated retinopathies.

Authors:  Tam V Bui; Yun Han; Roxana A Radu; Gabriel H Travis; Nathan L Mata
Journal:  J Biol Chem       Date:  2006-04-25       Impact factor: 5.157

2.  Assessment of rat and mouse RGC apoptosis imaging in vivo with different scanning laser ophthalmoscopes.

Authors:  Annelie Maass; Peter Lundh von Leithner; Vy Luong; Li Guo; Thomas E Salt; Frederick W Fitzke; M Francesca Cordeiro
Journal:  Curr Eye Res       Date:  2007-10       Impact factor: 2.424

3.  Acute central serous chorioretinopathy and fundus autofluorescence.

Authors:  Chiara M Eandi; Michael Ober; Reza Iranmanesh; Enrico Peiretti; Lawrence A Yannuzzi
Journal:  Retina       Date:  2005-12       Impact factor: 4.256

4.  Infrared fundus autofluorescence and central serous chorioretinopathy.

Authors:  Tetsuju Sekiryu; Tomohiro Iida; Ichiro Maruko; Kuniharu Saito; Takeshi Kondo
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-04-30       Impact factor: 4.799

5.  Fundus autofluorescence in acute and chronic-recurrent central serous chorioretinopathy.

Authors:  Carsten Framme; Andreas Walter; Bernhard Gabler; Johann Roider; Helmut G Sachs; Veit-Peter Gabel
Journal:  Acta Ophthalmol Scand       Date:  2005-04

6.  Abnormalities of fundus autofluorescence in central serous retinopathy.

Authors:  Andrea von Rückmann; Frederick W Fitzke; Joseph Fan; Anthony Halfyard; Alan C Bird
Journal:  Am J Ophthalmol       Date:  2002-06       Impact factor: 5.258

7.  Fundus autofluorescence of elongated photoreceptor outer segments in central serous chorioretinopathy.

Authors:  Hidetaka Matsumoto; Shoji Kishi; Taku Sato; Ryo Mukai
Journal:  Am J Ophthalmol       Date:  2011-01-22       Impact factor: 5.258

8.  Fundus autofluorescence and central serous chorioretinopathy.

Authors:  Richard F Spaide; James M Klancnik
Journal:  Ophthalmology       Date:  2005-05       Impact factor: 12.079

9.  Near-infrared and short-wavelength autofluorescence imaging in central serous chorioretinopathy.

Authors:  A Ayata; S Tatlipinar; T Kar; M Unal; D Ersanli; A H Bilge
Journal:  Br J Ophthalmol       Date:  2008-10-01       Impact factor: 4.638

10.  Three-dimensional configuration of subretinal fluid in central serous chorioretinopathy.

Authors:  Soh-Eun Ahn; Jaeryung Oh; Jong-Hyun Oh; In Kyung Oh; Seong-Woo Kim; Kuhl Huh
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-09-03       Impact factor: 4.799

View more
  4 in total

1.  Fundus autofluorescence findings in central serous chorioretinopathy using two different confocal scanning laser ophthalmoscopes: correlation with functional and structural status.

Authors:  Joo Youn Shin; Hun Jin Choi; Jonghyun Lee; Moonjung Choi; Byunghoon Chung; Suk Ho Byeon
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-12-22       Impact factor: 3.117

2.  FUNDUS AUTOFLUORESCENCE PATTERNS IN CENTRAL SEROUS CHORIORETINOPATHY.

Authors:  Jisang Han; Nam Suk Cho; Kiyoung Kim; Eung Suk Kim; Do Gyun Kim; Joon Mo Kim; Seung-Young Yu
Journal:  Retina       Date:  2020-07       Impact factor: 3.975

3.  Hyperpigmented spots at fundus examination: a new ocular sign in Neurofibromatosis Type I.

Authors:  Antonietta Moramarco; Fabiana Mallone; Marta Sacchetti; Luca Lucchino; Emanuele Miraglia; Vincenzo Roberti; Alessandro Lambiase; Sandra Giustini
Journal:  Orphanet J Rare Dis       Date:  2021-03-23       Impact factor: 4.123

4.  A Prediction Method of Visual Field Sensitivity Using Fundus Autofluorescence Images in Patients With Retinitis Pigmentosa.

Authors:  Tatsuya Inoue; Kosuke Nakajima; Yohei Hashimoto; Shotaro Asano; Kohdai Kitamoto; Kunihiro Azuma; Keiko Azuma; Kazuaki Kadonosono; Ryo Obata; Ryo Asaoka
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-08-03       Impact factor: 4.799

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.